Which of the following differentiates systolic heart failure (HF) from diastolic HF?
A. Systolic HF is caused by chronic hypertension. B. Systolic HF is associated with an ejection fraction of <> C. Systolic HF is associated with an ejection fraction of > 50%. D. Systolic HF has a better prognosis. • Which of the following medications from the VALIANT (Valsartan in Acute Myocardial Infarction Trial) study was found to be as effective for myocardial infarction as an angiotensin-converting enzyme (ACE) inhibitor (captopril)? A. Candesartan B. Losartan C. Irbesartan D. Valsartan • ACE inhibitor/angiotensin receptor blocker (ARB) combination therapy reduces mortality in which of the following disease states? A. Acute myocardial infarction (AMI) B. HF C. Nephropathy D. Hypertension • Which of the following regarding systolic HF is false? A. There have been significant advancements in the understanding of the pathology. B. There have been significant advances in treatment options. C. HF is no longer considered one of the leading cardiovascular diseases in terms of morbidity,
